# Pelthos Therapeutics Inc.: filings

PTHS · NYSE · CIK 1919246 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pths.md) · [Financials](/companies/pths/financials.md) · [Filings](/companies/pths/filings.md) · [Insiders](/companies/pths/insiders.md)

## Reports and events: 67 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 47, 8-K 34, 3 17, CORRESP 14, 424B3 13, S-1/A 13, UPLOAD 12, 4/A 11, 10-Q 8, EFFECT 6, SC 13G 6, SCHEDULE 13G/A 6, FWP 5, D 4, SCHEDULE 13G 4, 10-K 3, DEF 14A 3, POS AM 3, PRE 14A 3, 424B4 2, 425 2, ARS 2, POS EX 2, S-1 2, S-3 2, S-8 2, SEC STAFF LETTER 2, 10-Q/A 1, 144 1, 3/A 1, 8-A12B 1, 8-K12G3 1, 8-K/A 1, CERT 1, DEFA14A 1, DEFM14C 1, DRS 1, DRS/A 1, DRSLTR 1, NT 10-K 1, PREM14C 1, S-3/A 1, SC 13D 1, SC 13G/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 09:17 ET | [8-K](/filings/0001104659-26-120457.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120457 |
| 2026-10-01 | 17:15 ET | [8-K](/filings/0001919246-26-000125.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001919246-26-000125 |
| 2026-08-18 | 17:00 ET | [DEF 14A](/filings/0001919246-26-000120.md) | Proxy statement, period 2026-09-29 | 0001919246-26-000120 |
| 2026-08-13 | 07:20 ET | [10-Q](/filings/0001919246-26-000113.md) | Quarterly report, period 2026-06-30 | 0001919246-26-000113 |
| 2026-08-13 | 07:15 ET | [8-K](/filings/0001919246-26-000112.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000112 |
| 2026-08-13 | 07:06 ET | [10-Q/A](/filings/0001919246-26-000111.md) | Quarterly report, amended, period 2026-03-31 | 0001919246-26-000111 |
| 2026-08-13 | 07:00 ET | [8-K](/filings/0001919246-26-000110.md) | 4.02 Non-reliance on financial statements | 0001919246-26-000110 |
| 2026-05-28 | 17:01 ET | [8-K](/filings/0001919246-26-000085.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000085 |
| 2026-05-21 | 17:00 ET | [8-K](/filings/0001919246-26-000078.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001919246-26-000078 |
| 2026-05-14 | 07:08 ET | [8-K](/filings/0001919246-26-000071.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000071 |
| 2026-05-14 | 07:06 ET | [10-Q](/filings/0001919246-26-000070.md) | Quarterly report, period 2026-03-31 | 0001919246-26-000070 |
| 2026-04-14 | 08:42 ET | [8-K](/filings/0001919246-26-000060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000060 |
| 2026-04-10 | 17:04 ET | [8-K](/filings/0001919246-26-000058.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000058 |
| 2026-03-19 | 06:39 ET | [8-K](/filings/0001919246-26-000014.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001919246-26-000014 |
| 2026-03-19 | 06:37 ET | [10-K](/filings/0001919246-26-000013.md) | Annual report, period 2025-12-31 | 0001919246-26-000013 |
| 2026-01-13 | 08:30 ET | [8-K](/filings/0001753926-26-000097.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-26-000097 |
| 2026-01-12 | 16:31 ET | [8-K](/filings/0001753926-26-000094.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001753926-26-000094 |
| 2026-01-02 | 16:46 ET | [8-K](/filings/0001753926-26-000010.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-26-000010 |
| 2025-12-23 | 17:30 ET | [8-K](/filings/0001753926-25-001964.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001964 |
| 2025-12-17 | 16:15 ET | [8-K](/filings/0001753926-25-001906.md) | 5.07 Shareholder vote results | 0001753926-25-001906 |
| 2025-11-25 | 08:30 ET | [DEF 14A](/filings/0001753926-25-001827.md) | Proxy statement, period 2025-12-17 | 0001753926-25-001827 |
| 2025-11-13 | 06:50 ET | [8-K](/filings/0001753926-25-001766.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001766 |
| 2025-11-13 | 06:46 ET | [10-Q](/filings/0001753926-25-001764.md) | Quarterly report, period 2025-09-30 | 0001753926-25-001764 |
| 2025-11-07 | 08:01 ET | [8-K](/filings/0001753926-25-001715.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001715 |
| 2025-10-14 | 07:46 ET | [8-K](/filings/0001753926-25-001606.md) | 7.01 Regulation FD disclosure | 0001753926-25-001606 |
| 2025-09-16 | 16:10 ET | [8-K/A](/filings/0001753926-25-001500.md) | 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001753926-25-001500 |
| 2025-09-03 | 08:31 ET | [8-K](/filings/0001753926-25-001425.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001425 |
| 2025-08-18 | 08:05 ET | [8-K](/filings/0001753926-25-001353.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-001353 |
| 2025-08-13 | 16:39 ET | [10-Q](/filings/0001753926-25-001326.md) | Quarterly report, period 2025-06-30 | 0001753926-25-001326 |
| 2025-07-03 | 21:07 ET | [SCHEDULE 13D/A](/filings/0001753926-25-001081.md) | Ownership report, active investor, amended | 0001753926-25-001081 |
| 2025-07-02 | 17:22 ET | [8-K](/filings/0001753926-25-001055.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-001055 |
| 2025-05-13 | 16:31 ET | [10-Q](/filings/0001753926-25-000790.md) | Quarterly report, period 2025-03-31 | 0001753926-25-000790 |
| 2025-05-01 | 17:05 ET | [8-K](/filings/0001753926-25-000722.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-25-000722 |
| 2025-04-17 | 06:11 ET | [8-K](/filings/0001753926-25-000652.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-25-000652 |
| 2025-03-27 | 17:08 ET | [10-K](/filings/0001753926-25-000503.md) | Annual report, period 2024-12-31 | 0001753926-25-000503 |
| 2025-03-03 | 07:00 ET | [8-K](/filings/0001753926-25-000376.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001753926-25-000376 |
| 2024-11-21 | 09:00 ET | [8-K](/filings/0001753926-24-001983.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-001983 |
| 2024-11-18 | 17:03 ET | [8-K](/filings/0001753926-24-001955.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001753926-24-001955 |
| 2024-11-13 | 16:30 ET | [10-Q](/filings/0001753926-24-001883.md) | Quarterly report, period 2024-09-30 | 0001753926-24-001883 |
| 2024-10-24 | 08:30 ET | [8-K](/filings/0001753926-24-001759.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001759 |
| 2024-09-26 | 17:08 ET | [DEF 14A](/filings/0001140361-24-042069.md) | Proxy statement, period 2024-10-22 | 0001140361-24-042069 |
| 2024-08-13 | 16:31 ET | [10-Q](/filings/0001753926-24-001423.md) | Quarterly report, period 2024-06-30 | 0001753926-24-001423 |
| 2024-08-07 | 16:50 ET | [8-K](/filings/0001753926-24-001376.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001376 |
| 2024-07-29 | 09:15 ET | [S-1](/filings/0001753926-24-001279.md) | Registration statement | 0001753926-24-001279 |
| 2024-07-29 | 09:06 ET | [8-K](/filings/0001753926-24-001275.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-001275 |
| 2024-05-15 | 16:06 ET | [10-Q](/filings/0001753926-24-000976.md) | Quarterly report, period 2024-03-31 | 0001753926-24-000976 |
| 2024-04-16 | 16:48 ET | [10-K](/filings/0001753926-24-000740.md) | Annual report, period 2023-12-31 | 0001753926-24-000740 |
| 2024-04-09 | 08:30 ET | [8-K](/filings/0001753926-24-000691.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-000691 |
| 2024-03-21 | 09:00 ET | [8-K](/filings/0001753926-24-000584.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001753926-24-000584 |
| 2024-03-18 | 16:05 ET | [8-K](/filings/0001753926-24-000550.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001753926-24-000550 |

Page 1 of 2. [Older](/companies/pths/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:23 ET. No prices; not investment advice.